FIP IPS Medal Award
FIP Industrial Pharmacy Section Medal award recognises outstanding individuals that are making tremendous contributions within the pharmaceutical industrial sector globally. Every year, nominations for the award are received from individuals and pharmaceutical associations (both national and regional). After assessment by the FIP IPS executive committee, one person awardee is selected. The awardee is recognised at the IPS general assembly. The criteria for the award are as follows:
- Excellence in the practice of pharmaceutical sciences or pharmaceutical practice within an industrial (or related) environment.
- Influence and impact on industrial pharmacy developments beyond that of job responsibilities.
- ontribution over an extended period (several years) or very high impact over a shorter period international recognition (or exceptional national achievement).
- Demonstrated leadership skills.
- Demonstrated ability to build links with other branches of the profession (community, hospital, information, administrative pharmacy, etc.).
- Role model for young pharmacists.
The 2024 recipient of the FIP IPS Medal is Dr Stavros Nicolaou (South Africa), senior executive strategic trade at Aspen Pharma Group.
Dr Nicolaou is South Africa senior executive strategic trade at Aspen Pharma Group. He has almost 34 years’ experience in the pharmaceutical industry, mainly in domestic and international general management, has been recognised in the Global Top 100 Health Edition Honorees Most Influential People of African Descent (MIPAD) in health care and recently received Greece’s ARGO Public Service award from the President of Greece. He is a previous winner of the SA Institute of Marketing Management (Health Care Marketer of the year Award and has been inducted as a fellow of the Pharmaceutical Society of South Africa. He has been elected as an honorary member of the Southern African Society for Thrombosis and Haemostasis. He has received an honorary doctorate in medicine from Wits University and was awarded the Order of the Lion of St Mark by the Greek Orthodox Pope Theodoros II, and he is a recipient of the title of “High Commander of the Order of the Apostle & Evangelist Mark” of the Patriarchate of Alexandria. He is a member of the Holdings Group executive which has oversight of the more than 60 countries in which Aspen operates in globally. He serves on a number of industry boards and advisory councils. Dr Nicolaou is particularly passionate about diversity, transformation, championing localisation and building bridges between the private and public sector in order to improve access to treatment for patients in emerging markets and improving healthcare outcomes in these markets.
Previous IPS Medal winners include:
2023 Prof. Samuel Langer (USA), Massachusetts Institute of Technology
2021 Prof. Sarah Gilbert (UK), professor of vaccinology at Jenner Institute, University of Oxford
2020 Mr. Jude Nwokike (USA), vice president at USP and Director of the Promoting the Quality of Medicines plus (PQM+) program.
2018 Mr Luc Besançon (France), Executive Director of Neres
2015 Mr Tom Sam (Netherlands)
2013 Dr Thomas Lonngren (Sweden), director of PharmaExec Consulting, Greater Uppsala Metropolitan Area
Webinars
The IPS runs webinars throughout the year.
Join IPS for instant access to all past webinars.
- Manufacturing trends for CAR-T cell therapies (Douglas Miller) 2019
- Pharmacy in 2050. Forces That Will Shape Practice (Sola Solarin) 2017
- Sustainable Antibiotics; Antimicrobial Resistance (AMR). Pharmaceutical Industry Perspectives (Lucas Jan Wiarda) 2017
- Pharmacutical Patents (Joanna Brougher) 2017
- Data integrity (Michael Anisfeld) 2016
- The future of the industrial pharmaceutical profession (EFPIA) 2016
- Good distribution practice audits (Petra Lehtinen, Finland) 2015
- Pharmacovigilance audit II on common findings (Susanna Heinonen, Finland) 2015
- Pharmacovigilance audits I (Susanna Heinonen, Finland) 2015
- Current issues in biotechnology (Igor Linhares de Castro, Brazil) 2014
- Fundamentals and essentials of validation (Michael Anisfeld, USA) 2014
- Current developments in drug reg​ulation (Alan Chalmers, Switzerland) 2014
- Antibody drug conjugates (Matthew Cherian, USA) 2013
- Good distribution practices — Securing the supply chain (Michael Anisfeld, USA) 2013
- Supplier qualification goes beyond regulatory compliance (Wolfgang Löscher Filho, Brazil) 2013
- Passing a national regulatory inspection (Michael Anisfeld, USA) 2013
At the FIP congress
IPS activities at the 2017 FIP World Congress of Pharmacy and Pharmaceutical Sciences in Seoul, South Korea, included:
- Biosimilars for all: Research, regulation and responsible use (session)
- Individualized medicines: An ethical approach (session)
- Gene-based therapy (session)
- Supporting patients with chronic diseases (session)
- Counterfeit medicines: Safeguarding the supply chain, protecting people (session)
- Antimicrobial stewardship – Looking for global solutions (session)
- Shortages: The International Toronto Summit and beyond? (session)
- Short Oral Presentations
- Industry site visits
- Students half day
- IPS business meeting (membership assembly)
- IPS dinner
- Good Manufacturing Practices seminar
Topics organised by the IPS for recent FIP congresses (2014, 2015, 2016) include:
- Novel regulatory approaches to accelerate access to medicines
- Can pharmacists contribute to improving patient adherence as part of pharmacovigilance?
- Improving outcomes through novel technologies – Let’s innovate together!
- Biosimilars: Understanding the issues
- Student careers
- Industrial insights — potential careers in industrial pharmacy
- Good manufacturing practice seminar
- Compounding – A core competence for the pharmacist
- Medicines for all - Impediments to achieving the goal
- Transparency and social media - Empowering the pharmacist
- Lost in translation - Preserving scientific knowledge across languages
- Do patents limit access to new medicines?
- Is there a need to harmonise the training of industrial pharmacists?
- Insights into biosimilars and non-biological complex drugs
- Improving the quality of the information pharmacist provided to patients.
- Age-related medicines
- From development to marketing
FIP members have access to these presentations online.
Other events
- Symposium on New Frontiers in Manufacturing Technology, Regulatory Sciences and Pharmaceutical Quality System (SINDUSFARMA / ANVISA / FIP-IPS), held annually in Brazil in June each year.
Industrial Pharmacy journal
 |
Published quarterly in association with |